SCHUHSLER HELMUT

CIK 00011339215 companiesMUNICH, 2M

SEC Profile

Transactions

Companies

Filings

CIK

0001133921

Recent Transactions

50 trades

Purchase
Acer Therapeutics Inc.
Common Stock
2018-08-01$18.00/sh+275,000→ 1,697,709 total
Other
Acer Therapeutics Inc.
Common Stock
2017-09-19+227,485→ 227,485 total
Other
Acer Therapeutics Inc.
Common Stock
2017-09-19+663,782→ 663,782 total
Other
Acer Therapeutics Inc.
Common Stock
2017-09-19+1,172,709→ 1,172,709 total
Purchase
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2017-06-22$1000.00/sh+372→ 500 total
Purchase
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2017-06-22$1000.00/sh+372→ 500 total
Purchase
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2017-06-22$1000.00/sh+128→ 500 total
Award
CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (right to buy)
2015-06-11+10,000→ 10,000 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2014-10-27−1,531,518→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series C Convertible Preferred Stock
2014-10-27−799,043→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series C Convertible Preferred Stock
2014-10-27−2,331,391→ 0 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$4.60/sh+116,511→ 1,903,127 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A-1 Convertible Preferred Stock
2014-10-27−2,092,735→ 0 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$10.00/sh+223,410→ 223,410 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Warrants (Right to Buy)
2014-10-27−116,511→ 0 total
Other
Protara Therapeutics, Inc.$TARA
Option (Right to Purchase)
2014-10-27−1,316,683→ 0 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Warrants (Right to Buy)
2014-10-27−39,932→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series B Convertible Preferred Stock
2014-10-27−835,121→ 0 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$10.00/sh+76,590→ 300,000 total
Conversion
Protara Therapeutics, Inc.$TARA
Series D Convertible Preferred Stock
2014-10-27−1,277,663→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2014-10-27−4,468,482→ 0 total
Other
Protara Therapeutics, Inc.$TARA
Option (Right to Purchase)
2014-10-27−451,276→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27+379,462→ 1,786,616 total
Conversion
Protara Therapeutics, Inc.$TARA
Series D Convertible Preferred Stock
2014-10-27−3,727,823→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27+1,107,154→ 1,407,154 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$4.60/sh+39,932→ 1,943,059 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A-1 Convertible Preferred Stock
2014-10-27−717,260→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series B Convertible Preferred Stock
2014-10-27−2,436,618→ 0 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−88,877→ 370,187 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−274,880→ 1,144,932 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−66,506→ 276,999 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−274,880→ 1,178,534 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−66,506→ 285,129 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-04$38.82/sh−88,877→ 381,052 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-03$38.83/sh−1,402→ 343,505 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-03$38.83/sh−1,874→ 459,064 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-03$38.83/sh−1,402→ 351,635 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-03$38.83/sh−1,874→ 469,929 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-03$38.83/sh−5,795→ 1,453,414 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-03-03$38.83/sh−5,795→ 1,419,812 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-26$39.93/sh−8,283→ 353,037 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-26$39.93/sh−11,069→ 471,803 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-26$39.93/sh−34,237→ 1,459,209 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-25$38.92/sh−36,478→ 482,872 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-25$38.92/sh−112,826→ 1,493,446 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-25$38.92/sh−27,297→ 361,320 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-24$39.51/sh−8,130→ 380,487 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-24$39.51/sh−33,602→ 1,572,670 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-24$39.51/sh−10,865→ 508,485 total
Sale
ENANTA PHARMACEUTICALS INC$ENTA
Common Stock
2014-02-21$40.00/sh−5,034→ 1,606,272 total

Companies

Recent Filings

Address

C/O TVM CAPITAL MAXIMILIANSTRASSE 35C

MUNICH, 2M, 80539

View on SEC.gov